company background image
HCAT

Health Catalyst NasdaqGS:HCAT Stock Report

Last Price

US$15.40

Market Cap

US$834.4m

7D

-10.8%

1Y

-72.8%

Updated

01 Jul, 2022

Data

Company Financials +
HCAT fundamental analysis
Snowflake Score
Valuation1/6
Future Growth1/6
Past Performance0/6
Financial Health5/6
Dividends0/6

HCAT Stock Overview

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations.

Health Catalyst Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Health Catalyst
Historical stock prices
Current Share PriceUS$15.40
52 Week HighUS$59.50
52 Week LowUS$11.25
Beta1.19
1 Month Change9.77%
3 Month Change-44.26%
1 Year Change-72.83%
3 Year Changen/a
5 Year Changen/a
Change since IPO-60.68%

Recent News & Updates

Shareholder Returns

HCATUS Healthcare ServicesUS Market
7D-10.8%-3.4%-2.5%
1Y-72.8%-38.7%-21.2%

Return vs Industry: HCAT underperformed the US Healthcare Services industry which returned -40.4% over the past year.

Return vs Market: HCAT underperformed the US Market which returned -21.7% over the past year.

Price Volatility

Is HCAT's price volatile compared to industry and market?
HCAT volatility
HCAT Average Weekly Movement12.5%
Healthcare Services Industry Average Movement12.7%
Market Average Movement8.1%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.2%

Stable Share Price: HCAT is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: HCAT's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
20081,200Dan Burtonhttps://www.healthcatalyst.com

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017.

Health Catalyst Fundamentals Summary

How do Health Catalyst's earnings and revenue compare to its market cap?
HCAT fundamental statistics
Market CapUS$834.45m
Earnings (TTM)-US$147.30m
Revenue (TTM)US$254.17m

3.3x

P/S Ratio

-5.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
HCAT income statement (TTM)
RevenueUS$254.17m
Cost of RevenueUS$130.50m
Gross ProfitUS$123.67m
Other ExpensesUS$270.97m
Earnings-US$147.30m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-2.72
Gross Margin48.66%
Net Profit Margin-57.95%
Debt/Equity Ratio46.9%

How did HCAT perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is HCAT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for HCAT?

Other financial metrics that can be useful for relative valuation.

HCAT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2.6x
Enterprise Value/EBITDA-7.9x
PEG Ration/a

Price to Sales Ratio vs Peers

How does HCAT's PS Ratio compare to its peers?

HCAT PS Ratio vs Peers
The above table shows the PS ratio for HCAT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average7.5x
SLP Simulations Plus
20.2x17.8%US$1.0b
PHR Phreesia
5.8x25.4%US$1.3b
NXGN NextGen Healthcare
2x6.1%US$1.2b
CNVY Convey Health Solutions Holdings
2.2x13.8%US$762.0m
HCAT Health Catalyst
3.3x16.0%US$834.4m

Price-To-Sales vs Peers: HCAT is good value based on its Price-To-Sales Ratio (3.3x) compared to the peer average (7.5x).


Price to Earnings Ratio vs Industry

How does HCAT's PE Ratio compare vs other companies in the US Healthcare Services Industry?

Price-To-Sales vs Industry: HCAT is expensive based on its Price-To-Sales Ratio (3.3x) compared to the US Healthcare Services industry average (3.1x)


Price to Sales Ratio vs Fair Ratio

What is HCAT's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

HCAT PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio3.3x
Fair PS Ratio3x

Price-To-Sales vs Fair Ratio: HCAT is expensive based on its Price-To-Sales Ratio (3.3x) compared to the estimated Fair Price-To-Sales Ratio (3x).


Share Price vs Fair Value

What is the Fair Price of HCAT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate HCAT's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate HCAT's fair value for valuation analysis.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate HCAT's PEG Ratio to determine if it is good value.


Discover undervalued companies

Future Growth

How is Health Catalyst forecast to perform in the next 1 to 3 years based on estimates from 15 analysts?

Future Growth Score

1/6

Future Growth Score 1/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


5.2%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: HCAT is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: HCAT is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: HCAT is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: HCAT's revenue (16% per year) is forecast to grow faster than the US market (8.2% per year).

High Growth Revenue: HCAT's revenue (16% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: HCAT is forecast to be unprofitable in 3 years.


Discover growth companies

Past Performance

How has Health Catalyst performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


4.1%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: HCAT is currently unprofitable.

Growing Profit Margin: HCAT is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: HCAT is unprofitable, but has reduced losses over the past 5 years at a rate of 4.1% per year.

Accelerating Growth: Unable to compare HCAT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: HCAT is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (3.7%).


Return on Equity

High ROE: HCAT has a negative Return on Equity (-30.63%), as it is currently unprofitable.


Discover strong past performing companies

Financial Health

How is Health Catalyst's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: HCAT's short term assets ($482.5M) exceed its short term liabilities ($92.7M).

Long Term Liabilities: HCAT's short term assets ($482.5M) exceed its long term liabilities ($251.4M).


Debt to Equity History and Analysis

Debt Level: HCAT has more cash than its total debt.

Reducing Debt: Insufficient data to determine if HCAT's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: HCAT has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: HCAT has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 3.2% each year


Discover healthy companies

Dividend

What is Health Catalyst current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate HCAT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate HCAT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if HCAT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if HCAT's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as HCAT has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

1.7yrs

Average management tenure


CEO

Dan Burton (47 yo)

9.67yrs

Tenure

US$5,961,043

Compensation

Mr. Daniel D. Burton, also known as Dan, has been the Chief Executive Officer of Health Catalyst, Inc. since October 2012 and has been its Director since September 2011. Mr. Burton has strategy and leaders...


CEO Compensation Analysis

Compensation vs Market: Dan's total compensation ($USD5.96M) is above average for companies of similar size in the US market ($USD4.03M).

Compensation vs Earnings: Dan's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: HCAT's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.


Board Members

Experienced Board: HCAT's board of directors are considered experienced (5.1 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.7%.


Top Shareholders

Company Information

Health Catalyst, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Health Catalyst, Inc.
  • Ticker: HCAT
  • Exchange: NasdaqGS
  • Founded: 2008
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Implied Market Cap: US$834.450m
  • Shares outstanding: 54.19m
  • Website: https://www.healthcatalyst.com

Number of Employees


Location

  • Health Catalyst, Inc.
  • 10897 South River Front Parkway
  • Suite 300
  • South Jordan
  • Utah
  • 84095
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/07/01 00:00
End of Day Share Price2022/07/01 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.